ATE167662T1 - Verfahren zur herstellung eines lignan-derivats - Google Patents

Verfahren zur herstellung eines lignan-derivats

Info

Publication number
ATE167662T1
ATE167662T1 AT94912092T AT94912092T ATE167662T1 AT E167662 T1 ATE167662 T1 AT E167662T1 AT 94912092 T AT94912092 T AT 94912092T AT 94912092 T AT94912092 T AT 94912092T AT E167662 T1 ATE167662 T1 AT E167662T1
Authority
AT
Austria
Prior art keywords
compound
general formula
producing
lower alkyl
cycloalkyl
Prior art date
Application number
AT94912092T
Other languages
German (de)
English (en)
Inventor
Sachio Mori
Shozo Takechi
Shiro Kida
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of ATE167662T1 publication Critical patent/ATE167662T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
AT94912092T 1993-04-16 1994-04-12 Verfahren zur herstellung eines lignan-derivats ATE167662T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8994493 1993-04-16

Publications (1)

Publication Number Publication Date
ATE167662T1 true ATE167662T1 (de) 1998-07-15

Family

ID=13984820

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94912092T ATE167662T1 (de) 1993-04-16 1994-04-12 Verfahren zur herstellung eines lignan-derivats

Country Status (13)

Country Link
US (1) US5488134A (cg-RX-API-DMAC10.html)
EP (1) EP0646570B1 (cg-RX-API-DMAC10.html)
JP (1) JP3411036B2 (cg-RX-API-DMAC10.html)
KR (1) KR100277242B1 (cg-RX-API-DMAC10.html)
CN (1) CN1046937C (cg-RX-API-DMAC10.html)
AT (1) ATE167662T1 (cg-RX-API-DMAC10.html)
AU (1) AU666819B2 (cg-RX-API-DMAC10.html)
CA (1) CA2138264C (cg-RX-API-DMAC10.html)
DE (1) DE69411243T2 (cg-RX-API-DMAC10.html)
DK (1) DK0646570T3 (cg-RX-API-DMAC10.html)
ES (1) ES2119190T3 (cg-RX-API-DMAC10.html)
TW (1) TW255886B (cg-RX-API-DMAC10.html)
WO (1) WO1994024087A1 (cg-RX-API-DMAC10.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2121060C (en) * 1993-04-16 2004-04-06 Sachio Mori Preparation of lignan analogues
US6268392B1 (en) 1994-09-13 2001-07-31 G. D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6262277B1 (en) 1994-09-13 2001-07-17 G.D. Searle And Company Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
KR100376281B1 (ko) * 1995-12-26 2003-09-26 에스케이케미칼주식회사 리그난의 제조방법
EP1026167B1 (en) 1997-09-29 2003-03-05 Meiji Seika Kaisha Ltd. Tricyclic triazolobenzazepine derivatives, process for producing the same and antiallergic agents
WO2000038721A1 (en) 1998-12-23 2000-07-06 G.D. Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
DE69908644T2 (de) 1998-12-23 2004-05-13 G.D. Searle Llc, Chicago Kombnationen von cholesteryl ester transfer protein inhibitoren und gallensäure sequestriermitteln für kardiovaskuläre indikationen
PT1140188E (pt) 1998-12-23 2003-10-31 Searle Llc Combinacoes de inibidores do transporte de acidos biliares do ileo e de inibidores da proteina de transferencia de esteres de colesterilo para doencas cardiovasculares.
WO2000038722A1 (en) 1998-12-23 2000-07-06 G.D. Searle & Co. COMBINATIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG CoA REDUCTASE INHIBITORS FOR CARDIOVASCULAR INDICATIONS
US6562860B1 (en) 1998-12-23 2003-05-13 G. D. Searle & Co. Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
MXPA01006472A (es) 1998-12-23 2004-03-10 Searle Llc Combinaciones de inhibidores de transporte de acido biliar ileal y derivados de acido fibrico para indicaciones cardiovasculares.
AU776664B2 (en) 1998-12-23 2004-09-16 G.D. Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
WO2001068096A2 (en) * 2000-03-10 2001-09-20 Pharmacia Corporation Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
HK1052183A1 (zh) 2000-03-10 2003-09-05 Pharmacia Corporation 制造tetrahydrobenzothiepines的方法
US6740663B2 (en) 2001-11-02 2004-05-25 G.D. Searle, Llc Mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake
WO2003061604A2 (en) 2002-01-17 2003-07-31 Pharmacia Corporation Novel alkyl/aryl hydroxy or keto thiepines.
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
EP2575821B1 (en) 2010-05-26 2015-08-12 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
CA2852957C (en) 2011-10-28 2020-08-04 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
JP6217938B2 (ja) 2011-10-28 2017-10-25 ルメナ ファーマシューティカルズ エルエルシー 小児の胆汁うっ滞性肝疾患の処置のための胆汁酸再循環阻害剤
EP2968262A1 (en) 2013-03-15 2016-01-20 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of barrett's esophagus and gastroesophageal reflux disease
WO2014144650A2 (en) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
BR112021015815A2 (pt) 2019-02-12 2022-01-18 Mirum Pharmaceuticals Inc Métodos para tratar colestase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0372422A (ja) * 1989-05-16 1991-03-27 Tanabe Seiyaku Co Ltd 抗脂血剤
JPH03157351A (ja) * 1989-11-13 1991-07-05 Tanabe Seiyaku Co Ltd ナフタレン誘導体及びその製法
DK0597107T3 (da) * 1991-10-17 1996-07-29 Shionogi & Co Lignananalog, fremstilling deraf og hypolipidæmisk medikament

Also Published As

Publication number Publication date
EP0646570A4 (en) 1995-08-09
JP3411036B2 (ja) 2003-05-26
CA2138264C (en) 2004-04-06
DK0646570T3 (da) 1998-10-26
DE69411243D1 (de) 1998-07-30
AU666819B2 (en) 1996-02-22
CN1046937C (zh) 1999-12-01
KR950701902A (ko) 1995-05-17
US5488134A (en) 1996-01-30
TW255886B (cg-RX-API-DMAC10.html) 1995-09-01
WO1994024087A1 (fr) 1994-10-27
CN1109685A (zh) 1995-10-04
DE69411243T2 (de) 1998-11-19
EP0646570A1 (en) 1995-04-05
AU6437994A (en) 1994-11-08
CA2138264A1 (en) 1994-10-27
EP0646570B1 (en) 1998-06-24
KR100277242B1 (ko) 2001-02-01
ES2119190T3 (es) 1998-10-01

Similar Documents

Publication Publication Date Title
ATE167662T1 (de) Verfahren zur herstellung eines lignan-derivats
ATE229960T1 (de) Verfahren zur herstellung von 13-ether-derivaten von milbemycinen und zwischenprodukte
ATE121091T1 (de) Phospholipase a2-inhibitor, mikroorganismen, die diesen inhibitor erzeugen und mehrere verfahren zu seiner herstellung.
DE69304309D1 (de) Verfahren zur herstellung von taxan-derivaten
ATE186721T1 (de) Vitamin d3 derivat und verfahren zu dessen herstellung
DE69319764D1 (de) Verfahren zur Herstellung von Beta-Lactamderivaten und Zwischenprodukt für ihre Synthese
ATE141295T1 (de) Verfahren zur herstellung eines styrol-polymers
ATE138571T1 (de) Verwendung von dioxabicyclo (3.3.0>octane derivaten zur herstellung eines arzneimittels zur hemmung des cholesterinmetabolismus.
DE69707341D1 (de) Verfahren zur Herstellung von 4-Aryl-3-Hydroxymethyl-piperidinen
DK92295A (da) Fremgangsmåde til fremstilling af 1,4-benzoquinoner
ATE202071T1 (de) Verfahren zur herstellung von alph-beta- ungesättigten trifluormethylcarboxylverbindungen
ATE131169T1 (de) 2-pyranon-derivat und verfahren zu dessen herstellung.
ATE189453T1 (de) Verfahren zur herstellung von 2-cyanobiphenyl- verbindungen
DE69427978D1 (de) Zwischenprodukt zur verwendung in der synthese und verfahren zur herstellung eines aminopiperazinderivates
ATE236109T1 (de) Verfahren zur herstellung von 1,5-pentandiol- derivaten
ATE141583T1 (de) Alpha-methylencyclopentanon-derivate und verfahren zu ihrer herstellung
ES2074770T3 (es) Procedimiento de preparacion de derivados de 1,3-dioxano-4,6-diona.
ATE131483T1 (de) Verfahren zur herstellung von penemen
EP0974572A4 (en) NEW PROCESS FOR THE PRODUCTION OF ALCOHOLS
ATE277064T1 (de) Verfahren zur herstellung von vinylpyrimidinderivaten
FI915109A0 (fi) Foerfarande foer framstaellning av alifatisk amid och salter daerav.
ATE197949T1 (de) Verfahren zur herstellung von optisch aktivem (s)-(-)- und (r)-(+)- deoxyspergualin und zwischenprodukte dafür
ATE199372T1 (de) Verfahren zur herstellung von azacycloalkanderivaten
ATE92029T1 (de) Verfahren zur herstellung von 2-cyclohexenylcarboxylaten.
MX9800041A (es) Procedimiento mejorado para sintetizar intermediarios de carbapenem.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee